drugset / Trial / NCT05013242

Goserline Acetate VS Dienogest in Endometriosi

NCT05013242

Phase 4 Unknown 40 enrolled Mansoura University
RandomizedParallel-groupSingle-blindTreatment

Summary

clinical trial aims to evaluate efficacy of dienogest (DNG) in comparison to goserline acetate in complete 12 week treatment of pain in women suffer from chronic pelvic pain diagnosed as endometriosis by laparoscopy and histopathology.

Timeline

Start
2020-12-25
Primary completion
2021-11-25
Completion
2021-12-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dienogest Small molecule 2 mg Oral
Comparator Goserelin Other / unclassified 3.75 mg Other

Indications